4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0002028640-26-000007
Director sold 325 shares at $550.59 ($178,942)
- Director acquired 650 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
MALCOLM JAN · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-09 | Exercise or conversion : show line 1 in the form 10b5-1 | +650 | 775 | D | ||
| 2026-07-10 | Sale : show line 2 in the form 10b5-1 | −325 | $550.59 | $178,942 | 450 | D |
| Open-market sales · 325 sh · avg $550.59 · $178,942 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-09 | Exercise or conversion : show line 3 in the form 10b5-1 Restricted Stock Unit | −650 | 0 | D |
Loading xslF345X06/primarydocument.xml…